Correction to: Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialy

  • PDF / 454,365 Bytes
  • 7 Pages / 595.276 x 790.866 pts Page_size
  • 98 Downloads / 145 Views

DOWNLOAD

REPORT


CORRECTION

Correction to: Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients Shuichi Tsuruoka . Takamasa Endo

. Mizuna Seo . Naoto Hashimoto

Published online: September 15, 2020 Ó The Author(s) 2020 Correction to: Adv Ther (2020) 37:3234–3245 https://doi.org/10.1007/s12325-020-01375-1

In the original article, there is incorrect text has published as ‘‘The hemodialysis clearance, elimination fraction percentage, and amount of amenamevir removed were 37.8 mL/min, 28.1%, and 132.0 lg, respectively’’. The correct text is ‘‘The hemodialysis clearance, elimination fraction percentage, and amount of amenamevir removed were 41.4 mL/min, 30.7%, and 7919 lg, respectively’’.

The original article can be found online at https://doi. org/10.1007/s12325-020-01375-1. S. Tsuruoka Department of Nephrology, Nippon Medical School, Tokyo, Japan T. Endo (&)  M. Seo Clinical Development Department, Maruho Co., Ltd, Kyoto, Japan e-mail: [email protected] N. Hashimoto Drug Development Research Laboratory, Maruho Co., Ltd, Kyoto, Japan

The incorrect text has published as ‘‘There was no correlation between CLHD and Kt/V (A), but a strong negative correlation between EP and Kt/V (r = - 0.75) (C) was found, whereas the amount removed was positively correlated with Kt/V (r = 0.55) (E)’’. The correct text is ‘‘There was no correlation between CLHD and Kt/V (A), but a strong negative correlation between EP and Kt/V (r = - 0.77) (C) was found, whereas the amount removed was positively correlated with Kt/V (r = 0.58) (E)’’.

Adv Ther (2020) 37:4758–4764

4759

Original Table Table 4 Hemodialysis parameters of amenamevir and its major metabolite R5 (n = 9) Amenamevir

R5

Mean (SD)

Mean (SD)

Median Min–max

Median Min–max

Hemodialysis clearance (mL/min)

37.8 (5.3)

37.5

30.9–48.0

46.5 (4.4)

45.0

41.4–56.2

Hemodialysis clearance normalized with dialyzer surface area (mL/min/m2)

22.7 (5.4)

22.8

15.1–32.3

28.2 (7.4)

27.6

18.2–40.8

Elimination fraction percentage (%)

28.1 (5.1)

27.4

22.2–36.6

34.5 (4.7)

32.5

29.6–42.9

Removed amount (lg)

132.0 131.6 (54.2)

43.4–236.8 65.1 69.6 (28.7)

23.7–121.4

Max maximum; Min minimum, SD standard deviation

Corrected Table Table 4 Hemodialysis parameters of amenamevir and its major metabolite R5 (n = 9) Amenamevir

R5

Mean (SD)

Median Min–max

Mean (SD)

Median Min–max

Hemodialysis clearance (mL/min)

41.4 (5.0)

39.6

35.7–52.2

49.8 (4.6)

49.3

45.3–60.0

Hemodialysis clearance normalized with dialyzer surface area (mL/min/m2)

24.9 (5.9)

24.9

17.0–35.0

30.1 (7.9)

30.2

19.7–43.3

Elimination fraction percentage (%)

30.7 (4.8)

29.3

25.5–38.6

36.8 (4.5)

35.6

32.3–44.7

Removed amount (lg)

7919 7894 (3253)

2602–14,210 3905 4177 (1722)

1419–7282

Max maximum, Min minimum, SD standard deviation

Adv Ther (2020) 37:4758–4764

4760

Original Figure

B

50

Hemodialysis clearance (mL/min/m2)

Hemodialysis clearance (mL/min/m2)

A

45 40 35 30 25 20 15

y = 2.5122x + 25.465 R² = 0.0041

10 5 0

0

0